Published

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug and alcohol dependence
Date: 2012-06-01
Source: PubMed
DOI: 10.1016/j.drugalcdep.2011.10.029
PubMed: 22129843

Authors

Johnson MW Sewell RA Griffiths RR

Watch author

Derived topics and classifications

psilocybin Headache / Migraine Mechanism of Action Healthy Volunteers Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01 Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.2012-06-01

Related papers

Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Headache · 2011-03-01 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09 Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01 Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10 Repeat Dosing of Psilocybin in Headache DisordersClinicalTrials.gov · 2024-02-09 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01